Bicyclol Attenuates Obesity-Induced Cardiomyopathy via Inhibiting NF-κB and MAPK Signaling Pathways.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 6, p. 1131, doi. 10.1007/s10557-022-07356-6
- By:
- Publication type:
- Article
Works by Lin, Wante
Results: 4
1
2
Podocyte OTUD5 alleviates diabetic kidney disease through deubiquitinating TAK1 and reducing podocyte inflammation and injury.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-49854-1
- By:
- Publication type:
- Article
3
Tabersonine attenuates obesity‐induced renal injury via inhibiting NF‐κB‐mediated inflammation.
- Published in:
- Phytotherapy Research, 2023, v. 37, n. 6, p. 2353, doi. 10.1002/ptr.7756
- By:
- Publication type:
- Article
4
Tabersonine alleviates obesity‐induced cardiomyopathy by binding to Transforming growth factor activated kinase 1 (TAK1) and inhibiting TAK1‐mediated inflammation.
- Published in:
- Phytotherapy Research, 2023, v. 37, n. 3, p. 860, doi. 10.1002/ptr.7666
- By:
- Publication type:
- Article